Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis

Cancer Genetics and Cytogenetics

Volumn 110, Issue 2, 1999, Pages 87-93

  Koo, Sun Hoe ^a   Kwon, Kye Chul ^a   Ihm, Chun Hwa ^a   Jeon, Young Mi ^a   Park, Jong Woo ^a   Sul, Chong Koo ^a  

^a Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CHROMOSOME DELETION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; KARYOTYPE; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

AGED; CARCINOMA, PAPILLARY; CARCINOMA, TRANSITIONAL CELL; CHROMOSOME ABERRATIONS; CYTOGENETICS; FEMALE; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; URINARY BLADDER NEOPLASMS;

EID: 0033561344     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00193-9     Document Type: Article

References (34)

1. Tsai Y.C., Nicholas P.W., Hiti A.L., Williams Z., Skinner D.G., Jones P.A. Allelic losses of chromosome 9, 11, 17 in human bladder cancer. Cancer Res. 50:1990;44-47.
2. Dalbagni G., Presti J., Reuter V., Fair W.R., Cordon-Cardo C. Genetic alterations in bladder cancer. Lancet. 342:1993;469-471.
3. Knowles M.A., Elder P.A., Williams M.P., Cairns J.P., Shaw M.E., Law M.G. Allelotype of human bladder cancer. Cancer Res. 54:1994;531-538.
4. Shipman R., Schram P., Colombi M., Ludwig C.U. Loss of heterozygosity on chromosome 11p13 in primary bladder carcinoma. Hum Genet. 91:1993;455-458.
5. Perucca D., Szepetowski P., Simon M.-P., Gaudary P. Molecular genetics of human bladder carcinomas. Cancer Genet Cytogenet. 49:1990;143-156.
6. Moriyama-Gonda N., Shiina H., Himeno Y., Ishibe T. Unstable chromosome aberrations in bladder and renal cell carcinoma. Cancer Genet Cytogenet. 56:1991;65-72.
7. Kallionemi O.P., Kallionemi A., Piper J., Isola J., Waldman F.M., Gray W.J., Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer. 10:1994;231-243.
8. Houldsworth J., Chaganti S.K. Comparative genomic hybridization. an overview Am J Pathol. 145:1994;1253-1260.
9. Gibas Z., Gibas L. Cytogenetics of bladder cancer. Cancer Genet Cytogenet. 95:1997;108-115.
10. ISCN (1995): Guideline for Cancer Cytogenetics. Supplement to An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.
11. Telenius H., Pelmear A.H., Tunnacliffe A., Carter N.P., Behmel A., Furgoson-Smith M.A., Nordenskjöld M., Pfragner R., Ponder B.A.J. Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosom Cancer. 4:1992;257-263.
12. du Manoir S., Speicher M.R., Joos S., Schröck E., Popp S., Döhner H., Kovacs G., Robert-Nicoud M., Lichter P., Cremer T. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet. 90:1993;590-610.
13. Williamson M.P., Elder P.A., Shaw M.E., Delvin J., Knowles M.A. p16(CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum Mol Genet. 4:1995;1569-1577.
14. Orlow I., Lianes P., Lacombe L., Dalbagni G., Reuter V.E., Cardon-Cardo C. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res. 54:1994;2848-2851.
15. Tanaka M., Mullauer L., Ogiso Y., Fujita H., Moriya S., Furuuchi K., Harabayashi T., Shinohara N., Koyanagi T., Kuzumaki N. Gensolin. a candidate tumor supressor of human bladder cancer Cancer Res. 55:1995;3228-3232.
16. Shipman R., Schraml P., Colombi M., Raefle G., Ludwig C.U. Loss of heterozygosity on chromosome 11p in primary bladder carcinoma. Hum Genet. 91:1993;455-458.
17. Reznikoff C.A., Kao C., Messing E.M., Newton M., Swaminathan S. A molecular genetic model of human bladder carcinogenesis. Semin Cancer Biol. 4:1993;143-152.
18. Tarkanen M, Karhu R, Kallionemi A, Elomaa I, Kivioja AH, Nevalainen J, Böhling T, Karaharju E, Hyytinen E, Knuutila S, Kallionemi OP (1995): Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res 1334-1337.
19. Sandberg A.A., Berger C. Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. J Urol. 151:1994;545-560.
20. Kallionemi A., Kallionemi O.P., Citro G., Devris S., Kerschmann R., Caroll P., Waldman F. Identification of gains and losses of DNA sequence in primary bladder cancer by comparative genomic hybridization. Genes Chromosom Cancer. 12:1994;213-219.
21. Carins P., Shaw M.E., Knowles M.A. Preliminary mapping of the deleted region of chromosome 9 in bladder cancer. Cancer Res. 53:1993;1230-1232.
22. Voorter C., Joos S., Bringuier P.P., Vallinga M., Poddoghe P., Schalken J., du Manoir S., Ramaekers F., Lichter P., Hopman A. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am J Pathol. 146:1995;1341-1354.
23. Knowles M.A., Cairns J.P., Williamson M.P., Proctor A.J., Coombs L.M., Eydmann M.E. Identification of multiple molecular genetic alterations in bladder cancer. Cancer Genet Cytogenet. 63:1992;140-146.
24. Kinzler K.W., Nilbert M.C., Su L.K., Vogelstein B., Bryan T.M., Levy D.B., Smith K.J., Preisinger A.C., Hedge P., McKechnie D., Finniear R., Markham A., Groffen J., Boguski M.S., Altschul S.F., Horii A., Ando H., Miyoshi Y., Miki Y., Nishisho I., Nakamura Y. Identification of FAP locus genes from chromosome 5q21. Science. 252:1991;661-665.
25. Le Beau M.M., Espinosa R., Neuman W.L., Stock W., Roulston D., Larson R.A., Keinanen M., Westbrook C.A. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc Natl Acad Sci USA. 90:1993;5484-5488.
26. Richter J., Jiang F., Görög J.P., Sartorius G., Egenter C., Gasser T.C., Moch H., Mihatsch M.J., Sauter G. Marked genetic differences between stage pTa and pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res. 57:1997;2860-2864.
27. Yeager T.R., De Vries S., Jarrad D.F., Kao C., Nakada S.Y., Moon T.D., Bruskewitz R., Stadler W.M., Meinsner L.F., Gilchrist K.W., Newton M.A., Waldman F.M., Reznikoff C.A. Overcoming cellular senescence in human cancer pathogenesis. Genes Dev. 12:1998;163-174.
28. Cunningham C., Dunlop M.G., Wyllie A.H., Bird C.C. Deletion mapping on colorectal cancer of a putative tumor supressor gene in 8p22-p21.3. Oncogene. 8:1993;1391-1396.
29. Emi M., Fujiwara Y., Ohata H., Tsuda H., Hirohashi S., Koike M., Miyaki M., Monden M., Nakamura Y. Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma. Genes Chromosom Cancer. 7:1993;152-157.
30. Cher M.L., Macgrogan D., Bookstein R., Brown J.A., Jenkins R.B., Jensen R.H. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosom Cancer. 11:1994;153-162.
31. Wagner U., Bubendorf L., Gasser T.C., Moch H., Gorgor J.P., Richter J., Mihatsch M.J., Waldman F.M., Sauter G. Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer. Am J Pathol. 151:1997;753-759.
32. Kallionemi A., Kallionemi O.P., Citro G., Sauter G., Devries S., Kerschmann R., Caroll P., Waldman F. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosom Cancer. 12:1995;213-219.
33. Binger S.H., Vogelstein B. Cytogenetic and molecular genetics of malignant gliomas and medulloblastomas. Brain Pathol. 1:1990;12-18.
34. Nemoto R., Nakamura I., Uchida K., Harada M. Numerical chromosome aberrations in bladder cancer. Br J Urol. 75:1995;470-476.